Enanta Pharmaceuticals Inc
SWB:9EP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Enanta Pharmaceuticals Inc
SWB:9EP
|
US |
|
GCL New Energy Holdings Ltd
F:TJI
|
HK |
|
B
|
Bumi Armada Bhd
KLSE:ARMADA
|
MY |
|
G
|
General Environmental Conservation PCL
SET:GENCO
|
TH |
|
E
|
EGH Acquisition Corp
NASDAQ:EGHA
|
US |
|
H
|
HLB Pep Co Ltd
KOSDAQ:196300
|
KR |
|
E
|
Efor Cay Sanayi Ticaret AS
IST:EFORC.E
|
TR |
|
W
|
Wider Planet Inc
KOSDAQ:321820
|
KR |
|
A
|
Arion Technology Inc
KOSDAQ:058220
|
KR |
|
W
|
West Japan Railway Co
F:WEJ
|
JP |
|
First National Bank Alaska
OTC:FBAK
|
US |
|
C
|
Cryptology Asset Group PLC
XETRA:CAP
|
MT |
|
Dianthus Therapeutics Inc
F:87E
|
US |
|
F
|
FAR Ltd
OTC:FARYF
|
AU |
|
Korshunovskiy GOK PAO
MOEX:KOGK
|
RU |
|
S
|
Shin Ruenn Development Co Ltd
TPEX:6186
|
TW |
|
Libord Securities Ltd
BSE:531027
|
IN |
|
Guangdong Hong Kong Greater Bay Area Holdings Ltd
F:16H0
|
CN |
|
E
|
Elevate Service Group Inc
XTSX:SERV
|
CA |
|
Companhia de Eletricidade do Estado da Bahia Coelba
BOVESPA:CEEB3
|
BR |
|
Lassonde Industries Inc
TSX:LAS.A
|
CA |
|
S
|
Spruce Ridge Resources Ltd
OTC:SRCGF
|
CA |
|
S
|
Sodexo SA
XMUN:SJ7
|
FR |
Shareholder Yield
Current shareholder yield for 
9EP is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
9EP Price
Enanta Pharmaceuticals Inc
| Average Annual Return | -23.82% |
| Standard Deviation of Annual Returns | 57.62% |
| Max Drawdown | -95% |
| Market Capitalization | 373.6m EUR |
| Shares Outstanding | 120 925 287 |
| Percentage of Shares Shorted |
N/A
|
